Regulatory Factor X, a Bare Lymphocyte Syndrome Transcription Factor, Is a Multimeric Phosphoprotein Complex

Journal of Immunology

Volumn 158, Issue 12, 1997, Pages 5841-5848

  Moreno, Carlos S ^a   Rogers, Edward M ^a   Brown, Jeffrey A ^a   Boss, Jeremy M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; GAMMA INTERFERON; TRANSCRIPTION FACTOR; X BOX BINDING PROTEIN (RF X); X BOX BINDING PROTEIN (RF-X);

AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; COMBINED IMMUNODEFICIENCY; FIBROBLAST; GENE; GENETICS; HUMAN; LEUKEMIA CELL LINE; MOLECULAR GENETICS; PHOSPHORYLATION;

AMINO ACID SEQUENCE; DNA-BINDING PROTEINS; FIBROBLASTS; GENES, MHC CLASS II; HUMANS; INTERFERON TYPE II; JURKAT CELLS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; SEVERE COMBINED IMMUNODEFICIENCY; TRANSCRIPTION FACTORS;

EID: 0031570503     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Saito, T., and R. N. Germain. 1988. The molecular basis of MHC-restricted antigen recognition by T cells. Int. Rev. Immunol. 3:147.
2. Germain, R. N., N. S. Braunstein, M. A. Brown, L. H. Glimcher, R. I. Lechler, J. McCluskey, D. H. Margulies, J. Miller, M. A. Norcross, W. E. Paul, H. Quill, and F. Ronclese. 1986. Structure and function of murine class II major histocompatibility complex genes. Mt. Sinai J. Med. 53:194.
3. Unanue, E. R., C. V. Harding, I. F. Luescher, and R. W. Roof. 1989 Antigen-binding function of class II MHC molecules. Cold Spring Harbor Symp. Quant. Biol. 54:383.
4. Griscelli, C., B. Lisowska Grospierre, and B. Mach. 1989. Combined immunodeficiency with defective expression in MHC class II genes. Immunodefic. Rev. 1:135.
5. Mach, B., V. Steimle, and W. Reith. 1994. MHC class II-deficient combined immunodeficiency: a disease of gene regulation. Immunol. Rev. 138:207.
6. Benichou, B., and J. L. Strominger. 1991. Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc. Natl. Acad. Sci. USA 88: 4285.
7. Calman, A. F., and B. M. Peterlin. 1987. Mutant human B cell lines deficient in class II major histocompatibility complex transcription. J. Immunol. 139:2489.
8. Seidl, C., C. Saraiya, Z. Osterweil, Y. P. Fu, and J. S. Lee. 1992. Genetic complexity of regulatory mutants defective for HLA class II expression. J. Immunol. 148:1576.
9. Stimac, E., S. Urieli-Shoval, S. Kempin, and D. Pious. 1991. Defective HLA DRA X box binding in the class II transactive transcription factor mutant 6.1.6 and in cell lines from class II immunodeficient patients. J. Immunol. 146:4398.
10. Durand, B., M. Kobr, W. Reith, and B. Mach. 1994. Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX. Mol. Cell. Biol. 14:6839.
11. Steimle, V., B. Durand, B. Emmanuele, M. Zufferey, M. R. Hadam, B. Mach, and W. Reith. 1995. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 9:1021.
12. Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (bare lymphocyte syndrome). Cell 75:135.
13. Benoist, C., and D. Mathis. 1990. Regulation of major histocompatibility complex class-II genes: X, Y and other letters of the alphabet. Annu. Rev. Immunol. 8:681.
14. Boss, J. M., and J. L. Strominger. 1986. Regulation of a transfected human class II major histocompatibility complex gene in human fibroblasts. Proc. Natl. Acad. Sci. USA 83:9139.
15. Tsang, S. Y., M. Nakanishi, and B. M. Peterlin. 1988. B-cell-specific and interferon-gamma-inducible regulation of the HLA-DR alpha gene. Proc. Natl. Acad. Sci. USA 85:8598.
16. + cell types. J. Immunol. 146:1361.
17. Sloan, J. H., S. L. Hasegawa, and J. M. Boss. 1992. Single base pair substitutions within the HLA-DRA gene promoter separate the functions of the X1 and X2 boxes. J. Immunol. 148:2591.
18. Sloan, J. H., and J. M. Boss. 1988. Conserved upstream sequences of human class II major histocompatibility genes enhance expression of class II genes in wild-type but not mutant B-cell lines. Proc. Natl. Acad. Sci. USA 85:8186.
19. Hasegawa, S. L., J. L. Riley, J. H. Sloan, and J. M. Boss. 1993. Protease treatment of nuclear extracts distinguishes between class II major histocompatibility complex X1 box DNA-binding proteins in wild type and class II deficient B cells. J. Immunol. 150:1781.
20. Reith, W., S. Satola, C. Herrero-Sanchez, I. Amaldi, B. Lisowska-Grospierre, C. Griscelli, M. R. Hadam, and B. Mach. 1988. Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. Cell 53:897.
21. Herrero Sanchez, C., W. Reith, P. Silacci, and B. Mach. 1992. The DNA-binding defect observed in major histocompatibility complex class II regulatory mutants concerns only one member of a family of complexes binding to the X boxes of class II promoters. Mol. Cell. Biol. 12:4076.
22. Kara, C. J., and L. H. Glimcher. 1991. In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome. Science 252:709.
23. Hasegawa, S. L., and J. M. Boss. 1991. Two distinct B cell factors bind the HLA-DRA X box region and recognize different subsets of MHC class II promoters. Nucleic Acids Res. 19:6269.
24. Kobr, M., W. Reith, C. Herrero-Sanchez, and B. Mach. 1990. Two DNA-binding proteins discriminate between the promoters of different members of the major histocompatibility complex class II multigene family. Mol. Cell. Biol. 10:965.
25. Moreno, C. S., P. Emery, J. E. West, B. Durand, W. Reith, B. Mach, and J. M. Boss. 1995. Purified X2BP cooperatively binds the class II MHC X box region in the presence of purified RFX the X box factor deficient in the bare lymphocyte syndrome. J. Immunol. 155:4313.
26. Reith, W., C. A. Siegrist, B. Durand, E. Barras, and B. Mach. 1994. Function of major histocompalibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc. Natl. Acad. Sci. USA 91:554.
27. Coligan, J. E., A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, eds. 1991. Current Protocols in Immunology, Vol. 2. John Wiley and Sons, New York.
28. Shapiro, D. J., P. A. Sharp, W. W. Wahli, and M. J. Keller. 1988. A high-efficiency HeLa cell nuclear transcription extract. DNA 7:47.
29. Hasegawa, S. L., J. H. Sloan, W. Reith, B. Mach, and J. M. Boss. 1991. Regulatory factor-X binding to mutant HLA-DRA promoter sequences. Nucleic Acids Res. 19:1243.
30. Mantovani, R., U. Pessara, F. Tronche, X. Y. Li, A. M. Knapp, J.-L. Pasquali, C. Benoist, and D. Mathis. 1992. Monoclonal antibodies to NF-Y define its function in MHC class II and albumin gene transcription. EMBO J. 11:3315.
31. Li, X.-Y., R. van Huijsduijnen, R. Mantovani, C. Benoist, and D. Mathis. 1992. Intron-exon organization of the NF-Y genes. J. Biol. Chem. 267:8984.
32. Hooft van Huijsduijnen, R. A., X. Y. Li, D. Black, H. Matthes, C. Benoist, and D. Mathis. 1990. Co-evolution from yeast to mouse: cDNA cloning of the two NF-Y (CP-1/CBF) subunits. EMBO J. 9:3119.
33. Sinha, S., S. N. Maity, J. Lu, and B. De Crombrugghe. 1995. Recombinant rat CBF-C, the third subunit of CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and with yeast HAP2 and HAP3. Proc. Natl. Acad. Sci. USA 92:1624.
34. Hume, C. R., and J. S. Lee. 1989. Congenital immunodeficiencies associated with absence of HLA class II antigens on lymphocytes result from distinct mutations in trans-acting factors. Hum. Immunol. 26:288.
35. Steimle, V., C. A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1994. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265:106.
36. Chin, K.-C., C. Mao, C. Skinner, J. L. Riley, K. L. Wright, C. S. Moreno, G. R. Stark, J. M. Boss, and J. P.-Y. Ting. 1994. Molecular analysis of G1B and G3A IFN-γ mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Immunity 1:687.
37. Chang, C.-H., J. D. Fontes, B. M. Peterlin, and R. A. Flavell. 1994. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367.
38. Silacci, P., A. Mottet, V. Steimle, W. Reith, and B. Mach. 1994. Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA. J. Exp. Med. 180:1329.
39. Chang, C.-H., W. L. Fodor, and R. A. Flavell. 1992. Reactivation of a major histocompatibility complex class II gene in mouse plasmacytoma cells and mouse T cells. J. Exp. Med. 176:1465.
40. Chang, C.-H., and R. A. Flavell. 1995. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181:765.
41. Chang, C.-H., S. Guerder, S.-C. Hong, W. Van Ewijk, and R. A. Flavell. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4:167.
42. Chang, C., and R. A. Flavell. 1995. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 765:765.
43. Riley, J. L., S. D. Westerheide, J. A. Price, J. A. Brown, and J. M. Boss. 1995. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity 2:533.
44. Zhou, H., and L. H. Glimcher. 1995. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency. Immunity 2:545.
45. Riley, J. L., and J. M. Boss. 1993. Class II MHC transcriptional mutants are defective in higher order complex formation. J. Immunol. 151:6942.
46. Walker, J. E., M. Saraste, M. J. Runswick, and N. J. Gay. 1982. Distantly related sequences in the alpha-and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J. 1:945.
47. Saraste, M., P. R. Sibbald, and A. Wittinghofer. 1990. The P-loop: a common motif in ATP-binding and GTP-binding proteins. Trends. Biochem. Sci. 15: 430.
48. Pober, J. S., T. Collins, M. A. Gimbrone, Jr., R. S. Cotran, J. D. Gitlin, W. Fiers, C. Clayberger, A. M. Krensky, S. J. Burakoff, and C. S. Reiss. 1983. Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature 305:726.
49. Collins, T., A. J. Korman, C. T. Wake, J. M. Boss, D. J. Kappes, W. Fiers, K. A. Ault, M. A. Gimbrone, Jr., J. L. Strominger, and J. S. Pober. 1984. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc. Natl. Acad. Sci. USA 81:4917.
50. Gillis, S., and J. Watson. 1980. Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line. J. Exp. Med. 152:1709.